ConvaTec Group (LON:CTEC) had its price objective increased by Jefferies Financial Group from GBX 145 ($1.89) to GBX 220 ($2.87) in a report released on Friday morning, Digital Look reports. They currently have a buy rating on the stock.
Several other analysts have also recently weighed in on the stock. Goldman Sachs Group lifted their price objective on shares of ConvaTec Group from GBX 118 ($1.54) to GBX 183 ($2.39) and gave the stock a neutral rating in a research note on Wednesday, October 30th. Credit Suisse Group cut shares of ConvaTec Group to an underperform rating in a research note on Thursday, October 17th. UBS Group reiterated a neutral rating on shares of ConvaTec Group in a research note on Monday, October 28th. Shore Capital reiterated a buy rating on shares of ConvaTec Group in a research note on Friday, November 22nd. Finally, JPMorgan Chase & Co. reiterated a neutral rating and issued a GBX 171 ($2.23) price objective (down previously from GBX 174 ($2.27)) on shares of ConvaTec Group in a research note on Thursday, October 31st. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the company. ConvaTec Group has a consensus rating of Hold and an average target price of GBX 195.50 ($2.55).
Shares of ConvaTec Group stock opened at GBX 192.95 ($2.52) on Friday. ConvaTec Group has a twelve month low of GBX 113.25 ($1.48) and a twelve month high of GBX 211.60 ($2.76). The company has a quick ratio of 1.58, a current ratio of 2.37 and a debt-to-equity ratio of 104.76. The company has a 50-day simple moving average of GBX 189.53 and a two-hundred day simple moving average of GBX 167.12. The stock has a market capitalization of $3.83 billion and a price-to-earnings ratio of 24.12.
About ConvaTec Group
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.
Featured Article: Straddles
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.